Ventana PD-L1 (SP142) IHC Assay Reagent for Immunohistochemical Evaluation of Programmed Death Ligand-1 (PD-L1) in In Vitro Diagnostics with Ventana BenchMark Automated Immunostainers

Ventana PD-L1 (SP142) IHC Assay Reagent for Immunohistochemical Evaluation of Programmed Death Ligand-1 (PD-L1) in In Vitro Diagnostics with Ventana BenchMark Automated Immunostainers

The Ventana PD-L1 (SP142) IHC Assay reagent is designed for the immunohistochemical evaluation of programmed death ligand-1 (PD-L1) protein in in vitro diagnostics using automated immunostainers from the Ventana BenchMark series.

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, Ventana PD-L1 (SP142) IHC Assay Reagent for Immunohistochemical Evaluation of Programmed Death Ligand-1 (PD-L1) in In Vitro Diagnostics with Ventana BenchMark Automated Immunostainers, then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.